SCHEMBL9364671

SCHEMBL9364671

CCOC(=O)C(=O)Nc1cc(C(F)(F)F)ccc1[N+](=O)[O-]

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 2/20 0.60
KMT2A Q03164 4/20 0.55
ALDH1A1 P00352 3/20 0.55
CYP1A2 P05177 2/20 0.53
CYP2C19 P33261 2/20 0.53
MEN1 O00255 2/20 0.53
CYP3A4 P08684 1/20 0.53
MAPT P10636 5/20 0.52
AKR1B1 P15121 2/20 0.49
AKR1C4 P17516 1/20 0.49
AKR1C3 P42330 1/20 0.49
AKR1C2 P52895 1/20 0.49
AKR1C1 Q04828 1/20 0.49
CYP2C9 P11712 1/20 0.48
THRB P10828 2/20 0.46
PKM P14618 1/20 0.45
MAPK1 P28482 1/20 0.44
VDR P11473 1/20 0.44
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7976022 0.91 GPR35 (0.57) GPR35KMT2AALDH1A1CYP1A2CYP2C19
SCHEMBL9364666 0.85 AKR1B1 (0.53) KMT2AALDH1A1CYP1A2CYP2C19MEN1
SCHEMBL8139487 0.84 ALDH1A1 (0.58) GPR35KMT2AALDH1A1MAPTAKR1B1
SCHEMBL9365478 0.84 MAPT (0.67) GPR35KMT2AALDH1A1CYP1A2CYP2C19
SCHEMBL10432084 0.83 AKR1B1 (0.45) GPR35KMT2AALDH1A1CYP1A2CYP2C19
SCHEMBL9093727 0.81 L3MBTL1 (0.61) GPR35KMT2AALDH1A1MAPTAKR1B1
SCHEMBL9365437 0.81 GPR35 (0.64) GPR35KMT2AALDH1A1CYP1A2CYP2C19
SCHEMBL5973284 0.81 GPR35 (0.67) GPR35KMT2AALDH1A1CYP1A2CYP2C19
SCHEMBL9364718 0.81 SMN1; SMN2 (0.67) KMT2AALDH1A1CYP2C19MEN1MAPT
SCHEMBL9705730 0.80 KMT2A (0.50) GPR35KMT2AALDH1A1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0377112-B1 Quinoxaline compounds and their preparation and use NOVO NORDISK AS (DK) 1994-08-24 EP disclosed
US-5061706-A 2,3-QUINOXALINEDIONES FOR USE AS NEUROLEPTICS NOVO NORDISK A/S (DK) 1991-10-29 US disclosed
EP-0377112-A1 Quinoxaline compounds and their preparation and use NOVO NORDISK A/S (DK) 1990-07-11 EP disclosed